{
    "2021-05-11": [
        [
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：凯铭投资解押82.5万股及质押的350万股延期购回",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "凯铭投资",
                        "解押",
                        "质押",
                        "延期购回"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：股东凯铭投资解除质押82.5万股，延期购回350万股",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "凯铭投资",
                        "解除质押",
                        "延期购回"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华鑫证券：医药生物板块建议关注基本面稳健、估值相对合理的优质标的",
                "features": {
                    "keywords": [
                        "华鑫证券",
                        "医药生物",
                        "基本面稳健",
                        "估值合理",
                        "优质标的"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业双周报",
                "features": {
                    "keywords": [
                        "医药生物",
                        "双周报"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}